|
- Merck | Home
At Merck, we're following the science to tackle some of the world's greatest health threats Get a glimpse of how we work to improve lives
- Company fact sheet - Merck. com
Merck is a global health care company that delivers innovative health solutions through its prescription medicines, vaccines, biologic therapies, and animal health products
- History - Merck. com
Learn how Merck has created a legacy of inventing medicines and vaccines and become a leading global biopharmaceutical company over the past 130 years
- Who we are - Merck. com
Merck aspires to be the premier research-intensive biopharmaceutical company in the world Learn about our commitment to save and improve lives
- What we do - Merck. com
Merck aspires to be the premier research-intensive biopharmaceutical company in the world Learn about our commitment to save and improve lives
- Merck Announces Third-Quarter 2025 Dividend - Merck. com
RAHWAY, N J -- (BUSINESS WIRE)-- Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the Board of Directors has declared a quarterly dividend of $0 81 per share of the company’s common stock for the third quarter of 2025
- Merck Announces First-Quarter 2025 Financial Results
Merck continues to expect full-year 2025 sales to be between $64 1 billion and $65 6 billion, including a revised negative impact of foreign exchange of approximately 1% at mid-April 2025 exchange rates
- News releases - Merck. com
Merck Announces Positive Topline Results From the First Two Phase 3 CORALreef Trials Evaluating Enlicitide Decanoate for the Treatment of Adults With Hyperlipidemia
|
|
|